These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 22299629)

  • 21. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biodegradable, somatostatin acetate containing microspheres prepared by various aqueous and non-aqueous solvent evaporation methods.
    Herrmann J; Bodmeier R
    Eur J Pharm Biopharm; 1998 Jan; 45(1):75-82. PubMed ID: 9689538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method.
    Leo E; Pecquet S; Rojas J; Couvreur P; Fattal E
    J Microencapsul; 1998; 15(4):421-30. PubMed ID: 9651864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel method of preparing PLGA microcapsules utilizing methylethyl ketone.
    Sah H; Smith MS; Chern RT
    Pharm Res; 1996 Mar; 13(3):360-7. PubMed ID: 8692726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel preparation method for PLGA microspheres using non-halogenated solvents.
    Matsumoto A; Kitazawa T; Murata J; Horikiri Y; Yamahara H
    J Control Release; 2008 Aug; 129(3):223-7. PubMed ID: 18562036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New strategies for the microencapsulation of tetanus vaccine.
    Schwendeman SP; Tobío M; Joworowicz M; Alonso MJ; Langer R
    J Microencapsul; 1998; 15(3):299-318. PubMed ID: 9608394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reverse micelle-based microencapsulation of oxytetracycline hydrochloride into poly-d,l-lactide-co-glycolide microspheres.
    Kim H; Lee BJ; Sah H
    Drug Deliv; 2007 Feb; 14(2):95-9. PubMed ID: 17364873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery.
    Giovagnoli S; Blasi P; Schoubben A; Rossi C; Ricci M
    Int J Pharm; 2007 Mar; 333(1-2):103-11. PubMed ID: 17079101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification.
    Gasparini G; Kosvintsev SR; Stillwell MT; Holdich RG
    Colloids Surf B Biointerfaces; 2008 Feb; 61(2):199-207. PubMed ID: 17919891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compressed biodegradable matrices of spray-dried PLGA microspheres for the modified release of ketoprofen.
    Gavini E; Sanna V; Juliano C; Giunchedi P
    J Microencapsul; 2003; 20(2):193-201. PubMed ID: 12554374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel microencapsulation of potential drugs with low molecular weight and high hydrophilicity: hydrogen peroxide as a candidate compound.
    Ng SM; Choi JY; Han HS; Huh JS; Lim JO
    Int J Pharm; 2010 Jan; 384(1-2):120-7. PubMed ID: 19819316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Qualification of Non-Halogenated Organic Solvents Applied to Microsphere Manufacturing Process.
    Shim H; Sah H
    Pharmaceutics; 2020 May; 12(5):. PubMed ID: 32384751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of post-emulsification drying processes on the microencapsulation of human serum albumin.
    Lane ME; Brennan FS; Corrigan OI
    Int J Pharm; 2006 Jan; 307(1):16-22. PubMed ID: 16274944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin nanoparticle preparation and encapsulation into poly(lactic-co-glycolic acid) microspheres by using an anhydrous system.
    Han Y; Tian H; He P; Chen X; Jing X
    Int J Pharm; 2009 Aug; 378(1-2):159-66. PubMed ID: 19465100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
    Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
    Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug encapsulation in alginate microspheres by emulsification.
    Wan LS; Heng PW; Chan LW
    J Microencapsul; 1992; 9(3):309-16. PubMed ID: 1403481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel hemostatic delivery device for thrombin: biodegradable poly(D,L-lactide-co-glycolide) 50:50 microspheres.
    Smeets R; Gerhards F; Stein JM; Paz RM; Vogt S; Pautke C; Weitz J; Kolk A
    J Biomed Mater Res A; 2011 Jan; 96(1):177-85. PubMed ID: 21105166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Branched oligoester microspheres fabricated by a rapid emulsion solvent extraction method.
    Dittrich M; Hampl J; Soukup F
    J Microencapsul; 2000; 17(5):587-98. PubMed ID: 11038118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control of encapsulation efficiency in polymeric microparticle system of tolmetin.
    Jelvehgari M; Valizadeh H; Rezapour M; Nokhodchi A
    Pharm Dev Technol; 2010; 15(1):71-9. PubMed ID: 19505209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production of microspheres with surface amino groups from blends of Poly(Lactide-co-glycolide) and Poly(epsilon-CBZ-L-lysine) and use for encapsulation.
    Zheng J; Hornsby PJ
    Biotechnol Prog; 1999; 15(4):763-7. PubMed ID: 10441368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.